Many patients with high-risk biochemically recurrent prostate cancer based on PSA doubling time are unidentified in clinical practice. Clinicians unaware of patients’ PSA doubling time (PSADT) at ...

PSADT is vital for monitoring prostate cancer recurrence and guiding treatment decisions, yet often inaccurately calculated by physicians. Inconsistent PSADT documentation can lead to treatment delays ...

What happens to men with prostate cancer whose PSA starts to rise while on neo-adjuvant androgen ablation therapy prior to external radiation? No significant financial relationships to disclose. This ...

Antitumor effects of dual inhibition of the Src and insulin-like growth factor-1 receptor (IGF-1R) pathways in prostate cancer (PCa). Safety and efficacy of ketoconazole (K) in patients (pts) with ...

Men with rising PSA following initial therapy for localized prostate cancer experienced an increase in PSA doubling time (PSADT) after being treated with pomegranate extract, according to a new study.